This review covers the current aspects of leishmaniasis including marketed drugs, new antileishmanial agents, and possible drug targets of antileishmanial agents.
No takes yet. Share an insight, caveat, or question.
Sangshetti et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: